Skip to main content
OpenTrials
Completed

NCT Number: NCT02210650

Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

Patients with a ureteral or kidney stone that causes symptoms, like pain, frequently have small kidney stones that don't cause symptoms. If these small kidney stones are determined to be asymptomatic (not causing any problems or pain), then most urologists will simply remove the symptomatic ureteral stone and leave the additional stones in the kidneys. However, symptomatic kidney stones started as small stones that didn't cause symptoms. This means that the small stones remaining in the patient's kidney may cause problems later. The purpose of our research is to test if removing small stones from the kidney prevents future stone episodes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Indiana University Health, Indianapolis, Indiana, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled to undergo surgery (URS or PCNL) for a primary stone.
  • Computed tomography (CT) exam within the 90-day pre-operative period
  • Small (≤ 6mm) asymptomatic stones in visible on KUB or CT (i.e., calcium stones) in the contralateral kidney for a primary renal stone or ipsilateral kidney for primary ureteral stone.
  • Recurrent (having had previous stones) or multiple (simultaneous bilateral stones) stones
  • Able to give informed consent
  • Age 21 years or older

Exclusion criteria

  • Inability to give informed consent
  • Age less than 21 years
  • Stones not visible on KUB or CT
  • Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney)
  • Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could put the
  • subject at significant risk, confound the study results, or interfere significantly with the subject's
  • participation in the study.
  • Unwilling to participate.

Treatment and study plan

Symptomatic stone removal

Procedure

Symptomatic stone removal by the surgical procedures called Ureteroscopy or Percutaneous Nephrolithotomy

Asymptomatic kidney stones and ureteral stone removed

Procedure

Asymptomatic kidney stones and symptomatic stone removal by the surgical procedure called Ureteroscopy

Primary outcomes

  1. Relapse of stone disease on the study side

    Time frame: annually up to 5 years after stone removal surgery

    • Radiological evidence of significant growth in the size of any pre-existing stone
    • Return for stone removal surgery on the study side
    • Passage of a stone with pain symptoms on the study side resulting in an emergency department visit

Sponsors and collaborators

Lead sponsor

Indiana Kidney Stone Institute

Other

Collaborators

  • University of Washington
  • VA Puget Sound Health Care System

Registry information

Official study title

Randomized Controlled Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

Important dates

Study start
2014
Primary completion
2022
Study completion
2022
First posted
Aug 7, 2014
Registry last updated
May 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.